Sign in
8-K

Current Report

Tempest Therapeutics, Inc. Filed Acc 0001104659-18-030309

Results of operations · Exit or restructuring costs · Delisting notice · Executive or director change · Other events

  • Item 2.02 Results of operations and financial condition
  • Item 2.05 Costs associated with exit or disposal activities
  • Item 3.01 Notice of delisting or failure to meet a listing standard
  • Item 5.02 Departure or appointment of directors or officers
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading a18-12707_18k.htm…